BioCurex, Inc. Executive Chairman Denis Burger to Present at the 110th Quarterly FSX Conference in Atlanta
24 janv. 2011 07h00 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) will be a presenter at the 110th consecutive quarterly FSX conference. The Conference will take place January...
BioCurex, Inc. Executive Chairman Denis Burger to Present at the Fourth Annual OneMedForum Business Development and Finance Conference in San Francisco
10 janv. 2011 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Jan. 10, 2011 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) will be a presenter at the Fourth Annual OneMedForum Business Development and Finance Conference. The...
BioCurex to Host Shareholder Call on Wednesday, Dec. 15, at 4:10 p.m. EST (3:10 p.m. CST) for a Shareholder Update
13 déc. 2010 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Dec. 13, 2010 (GLOBE NEWSWIRE) -- BioCurex (OTCBB:BOCX) has announced that it will host a shareholder update conference call on Wednesday, Dec. 15, 2010, at 4:10 p.m. EST...
BioCurex Announces Filing of New Patent for Cancer Diagnostics, Therapeutics Based on Its Proprietary RECAF(TM) Technology
03 nov. 2010 17h21 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Nov. 3, 2010 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) -- today announced that it has filed a new patent within the Patent Cooperation Treaty, which presently...
BioCurex Announces Distribution Agreement for the European Union for Its OncoPet RECAF(TM) Cancer Test for Animals
13 oct. 2010 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Oct. 13, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) -- today announced that it has entered into a non-exclusive distribution agreement with VetRed B.V. from...
BioCurex Announces Commercial Launch of Its RECAF Blood Test to Detect Cancer in Dogs
30 sept. 2010 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Sept. 30, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) announced the commercial launch of its RECAF blood test for cancer in dogs through its wholly owned...
BioCurex CEO Highlights Recent Presentation of Its RECAF Test at International Scientific Meeting on Cancer Markers
20 sept. 2010 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, Sept. 20, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) CEO Dr. Ricardo Moro recently presented at the meeting of the International Society of Oncology and BioMarkers...
BioCurex Cancer Monitoring Data Accepted for Presentation at International Scientific Meeting on Cancer Markers
29 juil. 2010 09h30 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, July 29, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that the International Society of Oncology and Biomarkers Congress Scientific Committee has...
BioCurex Announces Positive First Results for Monitoring Cancer Therapy Using Its RECAF Blood Test
08 juil. 2010 09h35 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, July 8, 2010 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX ) today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer...
BioCurex, Inc. Executive Chairman Denis Burger to Present at the Renowned BIO International Convention in Chicago on May 6, 2010
04 mai 2010 09h25 HE
|
BioCurex, Inc.
RICHMOND, British Columbia, May 4, 2010 (GLOBE NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) will be a presenter at the BIO International Convention, the largest global event for the biotechnology...